Effect of Argatroban versus Recombinant Hirudin on Tissue-Factor-Mediated Thrombin Generation: An in Vitro Study
| Autor: | Léna Le Flem, Céline Guinet, Meyer Michel Samama, François Depasse |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
biology
Chemistry Antithrombin Hirudin Hematology Pharmacology In vitro Argatroban Tissue factor Thrombin Biochemistry Enzyme inhibitor biology.protein medicine Cardiology and Cardiovascular Medicine circulatory and respiratory physiology medicine.drug Discovery and development of direct thrombin inhibitors |
| Zdroj: | Seminars in Thrombosis and Hemostasis. 34:087-090 |
| ISSN: | 1098-9064 0094-6176 |
| DOI: | 10.1055/s-0028-1086087 |
| Popis: | Argatroban, a synthetic chemical compound, and recombinant hirudin (r-hirudin) are both direct thrombin inhibitors. Their actions are reversible and irreversible, respectively. We studied the influence of these two anticoagulants on the thrombin generation test using the method according to Hemker. For this investigation, a pool of citrated, platelet-poor, normal human plasma was supplemented with each drug at increasing concentrations. r-Hirudin had a dramatic influence on the initiation phase with almost no effect on the peak thrombin generated or the endogenous thrombin potential (ETP). In contrast, argatroban prolonged the initiation phase of thrombin generation and decreased the peak and ETP values. These differences are attributable to the irreversible and reversible binding to thrombin of these agents. This study reveals clear distinctions between the mechanisms of these two thrombin inhibitors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|